Insmed Reports First Quarter 2017 Financial Results and Provides Business Update
May 03, 2017 12:03 pm UTC| Business
Advancing Toward Top-Line Results from CONVERT Study in 2H 2017 Conference call today at8:30 AM ET BRIDGEWATER, N.J., May 03, 2017 -- Insmed Incorporated(Nasdaq:INSM), a global biopharmaceutical company focused on...
Nuvectra to Present at the 18th Annual B. Riley Co. Investor Conference
May 03, 2017 12:02 pm UTC| Business
PLANO, Texas, May 03, 2017 -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer Chief...
May 03, 2017 12:02 pm UTC| Business
BRIDGEWATER, N.J., May 03, 2017 -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that the Company will host a conference call with clinical experts to discuss their treatment of patients with diabetes and the...
NETSOL Technologies to Report Fiscal 2017 Third Quarter Results on May 15, 2017
May 03, 2017 12:02 pm UTC| Business
CALABASAS, Calif., May 03, 2017 -- NetSol Technologies, Inc. (Nasdaq:NTWK), leading global provider of enterprise application solutions and business services to the finance and leasing industry, will report its fiscal...
NETSOL Technologies to Report Fiscal 2017 Third Quarter Results on May 15, 2017
May 03, 2017 12:02 pm UTC| Business
CALABASAS, Calif., May 03, 2017 -- NetSol Technologies, Inc. (Nasdaq:NTWK), leading global provider of enterprise application solutions and business services to the finance and leasing industry, will report its fiscal...
NETSOL Technologies to Report Fiscal 2017 Third Quarter Results on May 15, 2017
May 03, 2017 12:02 pm UTC| Business
CALABASAS, Calif., May 03, 2017 -- NetSol Technologies, Inc. (Nasdaq:NTWK), leading global provider of enterprise application solutions and business services to the finance and leasing industry, will report its fiscal...
KaloBios to Host Company Overview Webinar on May 10
May 03, 2017 12:02 pm UTC| Business
BRISBANE, Calif., May 03, 2017 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, today announced it will host a...